11X Stock Market Accelerator Summit

Eric Fry reveals how an A.I.-based secret could make you up to 11 times RICHER on the same stocks you’re investing in now… without using options, leverage, or anything risky.

Wed, September 27 at 8:00PM ET

MBRX Stock Earnings: Moleculin Biotech Misses EPS Estimates


MBRX stock - MBRX Stock Earnings: Moleculin Biotech Misses EPS Estimates

Source: Shutterstock

Moleculin Biotech (NASDAQ:MBRX) reported first quarter results for 2023.

  • Moleculin Biotech reported a loss per share of 28 cents.
  • That was worse than the analyst estimate for a loss of 25 cents.
  • The company did not report any revenue for the quarter.
  • You can read the full Moleculin Biotech press release here.

On the date of publication, Sarah Smith did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.

Sarah Smith is the Editor-in-Chief of InvestorPlace.com.

Article printed from InvestorPlace Media, https://investorplace.com/2023/05/mbrx-stock-earnings-moleculin-biotech-misses-eps-estimates/.

©2023 InvestorPlace Media, LLC